2015 - Fellow of the American Psychological Association (APA)
Maxine L. Stitzer mainly investigates Methadone, Anesthesia, Substance abuse, Psychiatry and Abstinence. Her Methadone study focuses on Methadone maintenance in particular. Her Anesthesia study incorporates themes from Clinical trial, Buprenorphine, Opioid, Placebo and Dosing.
The various areas that Maxine L. Stitzer examines in her Substance abuse study include Biopsychosocial model, Psychopathology, Addiction and Contingency management. The Psychiatry study combines topics in areas such as Clinical psychology and Opiate. Her studies in Abstinence integrate themes in fields like Social psychology, Reinforcement, Randomized controlled trial and Nicotine.
Her scientific interests lie mostly in Psychiatry, Substance abuse, Methadone, Anesthesia and Abstinence. Her research ties Clinical psychology and Psychiatry together. The study incorporates disciplines such as Clinical trial, Stimulant, Psychosocial, Reinforcement and Addiction in addition to Substance abuse.
Her Methadone study integrates concerns from other disciplines, such as Urinalysis, Heroin and Opiate. Her research investigates the link between Anesthesia and topics such as Opioid that cross with problems in Pharmacology. Her Abstinence research includes elements of Internal medicine, Randomized controlled trial, Nicotine and Ambulatory care.
Maxine L. Stitzer mostly deals with Psychiatry, Substance abuse, Contingency management, Abstinence and Psychological intervention. Psychiatry connects with themes related to Buprenorphine in her study. Her Buprenorphine study is concerned with the field of Opioid as a whole.
Her work in Substance abuse tackles topics such as Clinical trial which are related to areas like Medical education and Cocaine dependence. Her studies deal with areas such as Applied psychology and Clinical psychology as well as Contingency management. Many of her research projects under Abstinence are closely connected to Demography with Demography, tying the diverse disciplines of science together.
Her primary areas of study are Psychiatry, Psychological intervention, Contingency management, Abstinence and Randomized controlled trial. Maxine L. Stitzer interconnects Opiate Substitution Treatment and Buprenorphine in the investigation of issues within Psychiatry. Maxine L. Stitzer combines subjects such as Clinical trial, Intervention, Family medicine, Substance abuse and Physical therapy with her study of Psychological intervention.
Her work carried out in the field of Contingency management brings together such families of science as Substance abuse treatment and Clinical psychology. Her work in the fields of Drug Abstinence overlaps with other areas such as Demography. Her Methadone study contributes to a more complete understanding of Anesthesia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
S. L. Walsh;K. L. Preston;M. L. Stitzer;E. J. Cone.
Clinical Pharmacology & Therapeutics (1994)
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Rolley E. Johnson;Mary Ann Chutuape;Eric C. Strain;Sharon L. Walsh.
The New England Journal of Medicine (2000)
Moderate- Vs High-Dose Methadone in the Treatment of Opioid Dependence: A Randomized Trial
Eric C. Strain;George E. Bigelow;Ira A. Liebson;Maxine L. Stitzer.
JAMA (1999)
Effect of Prize-Based Incentives on Outcomes in Stimulant Abusers in Outpatient Psychosocial Treatment Programs: A National Drug Abuse Treatment Clinical Trials Network Study
Nancy M. Petry;Jessica M. Peirce;Maxine L. Stitzer;Jack Blaine.
Archives of General Psychiatry (2005)
THE AGENCY FOR HEALTH CARE POLICY AND RESEARCH SMOKING CESSATION CLINICAL PRACTICE GUIDELINE
Michael C. Fiore;David W. Wetter;William C. Bailey;Glen Bennett.
JAMA (1996)
Comparison of buprenorphine and methadone in the treatment of opioid dependence
Eric C. Strain;Maxine L. Stitzer;Ira A. Liebson;George E. Bigelow.
American Journal of Psychiatry (1994)
A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
Warren K Bickel;Warren K Bickel;Maxine L Stitzer;Maxine L Stitzer;George E Bigelow;George E Bigelow;Ira A Liebson;Ira A Liebson.
Clinical Pharmacology & Therapeutics (1988)
Cognitive impairment in methadone maintenance patients
Miriam Z Mintzer;Maxine L Stitzer.
Drug and Alcohol Dependence (2002)
Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Jessica M. Peirce;Nancy M. Petry;Maxine L. Stitzer;Jack Blaine.
Archives of General Psychiatry (2006)
Dose-response effects of methadone in the treatment of opioid dependence.
Eric C. Strain;Maxine L. Stitzer;Ira A. Liebson;George E. Bigelow.
Annals of Internal Medicine (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University School of Medicine
University of Vermont
Johns Hopkins University School of Medicine
University of Connecticut
Virginia Commonwealth University
Johns Hopkins University School of Medicine
Washington State University
National Institute on Drug Abuse
Johns Hopkins University School of Medicine
Brown University
Johns Hopkins University
Bocconi University
Chalmers University of Technology
Qingdao University of Science and Technology
Huazhong University of Science and Technology
Murdoch Children's Research Institute
The University of Texas at Austin
Nanjing University
Oklahoma Medical Research Foundation
The University of Texas Health Science Center at Houston
Erasmus University Rotterdam
Hiroshima University
Erasmus University Rotterdam
University of Exeter
University of Sheffield
University of South Florida